InfuSystem (NYSE:INFU) Upgraded at StockNews.com

InfuSystem (NYSE:INFU - Get Free Report) was upgraded by stock analysts at StockNews.com from a "buy" rating to a "strong-buy" rating in a research note issued to investors on Friday.

InfuSystem Trading Up 0.9 %

INFU traded up $0.05 during midday trading on Friday, reaching $5.80. 83,564 shares of the company's stock traded hands, compared to its average volume of 74,104. The firm has a fifty day moving average of $7.60 and a two-hundred day moving average of $7.56. The stock has a market capitalization of $121.85 million, a price-to-earnings ratio of 96.68 and a beta of 1.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. InfuSystem has a 52 week low of $5.29 and a 52 week high of $9.97.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. First Eagle Investment Management LLC grew its holdings in shares of InfuSystem by 25.9% during the 4th quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company's stock worth $7,676,000 after acquiring an additional 186,668 shares during the period. Meros Investment Management LP grew its holdings in shares of InfuSystem by 2.6% during the 4th quarter. Meros Investment Management LP now owns 631,105 shares of the company's stock worth $5,333,000 after acquiring an additional 16,178 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of InfuSystem by 5.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 456,043 shares of the company's stock worth $3,853,000 after acquiring an additional 21,697 shares during the period. Geode Capital Management LLC grew its holdings in shares of InfuSystem by 1.8% during the 4th quarter. Geode Capital Management LLC now owns 444,476 shares of the company's stock worth $3,756,000 after acquiring an additional 7,968 shares during the period. Finally, Renaissance Technologies LLC grew its holdings in shares of InfuSystem by 2.6% during the 4th quarter. Renaissance Technologies LLC now owns 337,609 shares of the company's stock worth $2,853,000 after acquiring an additional 8,700 shares during the period. Institutional investors own 71.13% of the company's stock.

Remove Ads

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.